Therapeutic Efficacy and Safety of Methotrexate in Moderate-to-Severe Atopic Dermatitis: A Retrospective Study of Korean Patients at Tertiary Referral Hospital

BACKGROUND: Methotrexate (MTX) has been prescribed to suppress atopic dermatitis (AD) symptoms and flares in moderate-to-severe cases. OBJECTIVE: The purpose of this study was to evaluate the therapeutic efficacy and safety of MTX as well as the suppressive activity of MTX to reduce flares in modera...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hong, Yun, Sook-Jung, Lee, Jee-Bum, Lee, Seung-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992581/
https://www.ncbi.nlm.nih.gov/pubmed/33911775
http://dx.doi.org/10.5021/ad.2020.32.5.402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992581/
https://www.ncbi.nlm.nih.gov/pubmed/33911775
http://dx.doi.org/10.5021/ad.2020.32.5.402

Ejemplares similares